← Back to Clinical Trials
Recruiting NCT04404114

NCT04404114 Shear Wave Elastography in Differentiating Acute or Chronic Kidney Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04404114
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Elastography
Study Type OBSERVATIONAL
Enrollment 800 participants
Start Date 2020-02-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Shear wave elastography to distinguish AKI from normal kidneyShear wave elastography to distinguish AKI from CKDShear wave elastography to distinguish CKD from normal kidney

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 800 participants in total. It began in 2020-02-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic kidney disease is a common global public health issue and its prevalence increased year by year. Early diagnosis and intervention can prevent further complications and comorbidities of long-term dialysis, cardiovascular events and mortality as well as improve the patients' life quality. To differentiate acute from chronic kidney disease was crucial especially in the setting of crowded and high-risk emergency department. To diagnose acute or chronic kidney disease, physicians usually use blood sample test combined with image studies such as conventional sonography, CT and MRI. However, there was lots of limited factors. The patients may have no previous visit records, poor renal function to receive contrast medium, or critical clinical condition to undergo time-wasting exam. Although the conventional renal sonography is accessible and inexpensive, the judgement is subjective and provide little clinical information. Recent researches of shear wave elastography in evaluating renal parenchymal stiffness showed some correlation with nephropathy. In our study, aiming to facilitating clinical implication, the investigators will use swear-wave elastography combined with conventional renal sonography to benefit patients in diagnosis of acute or chronic kidney disease.

Eligibility Criteria

Inclusion Criteria: * The patients older than 20 years old who needed to receive renal sonography in emergency department of National Taiwan University Hospital. Exclusion Criteria: * The patients who didn't obtain agreement. * The patients who can't cooperate or follow the directions

Contact & Investigator

Central Contact

Wan C. Lien, A.P

✉ dtemer17@yahoo.com.tw

📞 +886 972651315

Frequently Asked Questions

Who can join the NCT04404114 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Elastography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04404114 currently recruiting?

Yes, NCT04404114 is actively recruiting participants. Contact the research team at dtemer17@yahoo.com.tw for enrollment information.

Where is the NCT04404114 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT04404114 clinical trial?

NCT04404114 is sponsored by National Taiwan University Hospital. The trial plans to enroll 800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology